Research Article

Prevalence and Associated Factors of Portopulmonary Hypertension in Patients with Portal Hypertension: A Case-Control Study

Table 3

Analysis of laboratory examination of the POPH group and non-POPH group.

EchocardiographyPOPH ()Non-POPH ()

Enlargement of the left atrium (%)
Normal10 (35.7)132 (82.5)28.224<0.01
Enlargement18 (64.3)28 (17.5)
Enlargement of the left ventricle (%)
Normal22 (78.6)153 (95.6)<0.01
Enlargement6 (21.4)7 (4.4)
Enlargement of the right atrium (%)
Normal13 (46.4)165 (96.9)<0.01
Enlargement15 (53.6)5 (3.1)
Enlargement of the right ventricle (%)
Normal25 (89.3)158 (98.8)0.024
Enlargement3 (10.7)2 (1.2)
Pericardial effusion (%)
Yes12 (42.9)12 (7.5)<0.01
No16 (57.1)148 (92.5)
Mitral regurgitation (%)
Yes16 (57.1)25 (15.6)24.088<0.01
No12 (42.9)135 (84.4)
Aortic regurgitation (%)
Yes8 (28.6)17 (10.6)0.016
No20 (71.4)143 (89.4)
Pulmonary regurgitation (%)
Yes1 (3.6)1 (0.6)0.276
No27 (96.4)159 (99.4)
Tricuspid regurgitation (%)
Yes26 (92.9)37 (23.1)52.006<0.01
No2 (96.4)123 (76.9)
Pulmonary artery widening (%)
Yes10 (35.7)0 (0)<0.01
No18 (64.3)160 (100.0)
Diastolic function (%)
Normal2 (7.1)28 (17.5)-1.7810.075
Suspicious reduction6 (21.4)45 (28.2)
Reduction20 (57.5)87 (54.3)
Left ventricular short-axis contraction rate (%)32 (31-33)32 (30-33)-1.0080.313
Ejection fraction (%)60 (59-64)60 (60-63)-0.6530.514

Fisher’s exact test.